Patents by Inventor Fred Y. Edamura

Fred Y. Edamura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4496440
    Abstract: Mono- or dimethylol compounds having water solubilities of 3 grams or less per 100 grams of water are electrochemically oxidized to the corresponding mono- or dicarboxylic acids at activated nickel oxide anodes. The methylol compounds are adducts of 1,2-alkylene oxides with phenols, pyridinols, bisphenols, phenoxy- or pyridinyloxypyridinols or are polycycloaliphatics ring-substituted with one or two CH.sub.2 OH groups.
    Type: Grant
    Filed: June 4, 1984
    Date of Patent: January 29, 1985
    Assignee: The Dow Chemical Company
    Inventors: Kent D. Campbell, Aylin H. Gulbenkian, Fred Y. Edamura, Demetrios Kyriacou
  • Patent number: 4217185
    Abstract: Electrolytic reduction of tetrachloro-2-picolinic acid in basic aqueous solution, at an activated silver cathode, yields the 3,4,6- and 3,5,6-trichloro-2-picolinic acids, which in turn may be further reduced to 3,6-dichloropicolinic acid, a highly active herbicide.
    Type: Grant
    Filed: July 2, 1979
    Date of Patent: August 12, 1980
    Assignee: The Dow Chemical Company
    Inventors: Demetrios Kyriacou, Fred Y. Edamura, Jim Love
  • Patent number: 3966937
    Abstract: Methyl-(4-methylphenyl)-substituted-tetrazolo-(1,5-a)pyrimidine and methods employing the same for the systemic protection of plants from soil-borne plant disease organisms.
    Type: Grant
    Filed: January 20, 1975
    Date of Patent: June 29, 1976
    Assignee: The Dow Chemical Company
    Inventors: Fred Y. Edamura, Ronald J. Sbragia
  • Patent number: 3961059
    Abstract: Disclosed are novel 6-(substituted phenoxy)-tetrazolo(1,5-b)pyridazine compounds and methods employing the same for protecting plants from soil-borne disease both prior to infection and after infection by systemically killing and controlling the disease organisms.
    Type: Grant
    Filed: May 1, 1975
    Date of Patent: June 1, 1976
    Assignee: The Dow Chemical Company
    Inventor: Fred Y. Edamura